1.GRAVITAS-301: GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease
Study Locations in Greece:
General Hospital of Thessaloniki G. Papanikolaou – Hematology Department
University General Hospital of Patras
University Hospital of West Attica – Attikon – Hematology Division, Athens (Not yet recruiting)
2. Protocol Nο.:2215-CL-0304 A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Trial of the FLT3 Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/ITD AM
Study Locations in Greece:
General Hospital of Thessaloniki G. Papanikolaou – Hematology Department
University General Hospital of Patras